{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:12:34Z","timestamp":1763705554449,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":107,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493987955"},{"type":"electronic","value":"9781493987962"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-8796-2_23","type":"book-chapter","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T11:59:43Z","timestamp":1549454383000},"page":"285-310","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Homocysteine, Thioretinaco Ozonide, and Oxidative Phosphorylation in Cancer and Aging: A Proposed Clinical Trial Protocol"],"prefix":"10.1007","author":[{"given":"Kilmer S.","family":"McCully","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"key":"23_CR1","first-page":"477","volume":"23","author":"KS McCully","year":"1993","unstructured":"McCully KS (1993) Chemical pathology of homocysteine. I. Atherogenesis. Ann Clin Lab Sci 23:477\u2013493","journal-title":"Ann Clin Lab Sci"},{"key":"23_CR2","first-page":"27","volume":"24","author":"KS McCully","year":"1994","unstructured":"McCully KS (1994) Chemical pathology of homocysteine. II. Carcinogenesis and homocysteine thiolactone metabolism. Ann Clin Lab Sci 24:27\u201359","journal-title":"Ann Clin Lab Sci"},{"key":"23_CR3","first-page":"134","volume":"24","author":"KS McCully","year":"1994","unstructured":"McCully KS (1994) Chemical pathology of homocysteine. III. Cellular function and aging. Ann Clin Lab Sci 24:134\u2013152","journal-title":"Ann Clin Lab Sci"},{"key":"23_CR4","first-page":"219","volume":"39","author":"KS McCully","year":"2009","unstructured":"McCully KS (2009) Chemical pathology of homocysteine. IV. Excitotoxicity, oxidative stress, endothelial dysfunction, and inflammation. Ann Clin Lab Sci 39:219\u2013232","journal-title":"Ann Clin Lab Sci"},{"key":"23_CR5","first-page":"300","volume":"41","author":"KS McCully","year":"2011","unstructured":"McCully KS (2011) Chemical pathology of homocysteine. V. Thioretinamide, thioretinaco, and cystathionine synthase function in degenerative diseases. Ann Clin Lab Sci 41:300\u2013313","journal-title":"Ann Clin Lab Sci"},{"key":"23_CR6","first-page":"401","volume":"6","author":"KS McCully","year":"2016","unstructured":"McCully KS (2016) Homocysteine metabolism, atherosclerosis, and diseases of aging. Compr Physiol 6:401\u2013475","journal-title":"Compr Physiol"},{"key":"23_CR7","first-page":"331","volume-title":"Homocysteine in health and disease","author":"H Blom","year":"2001","unstructured":"Blom H (2001) Diseases and drugs associated with hyperhomocysteinemia. In: Carmel R, Jacobsen DW (eds) Homocysteine in health and disease. Cambridge University Press, Cambridge, pp 331\u2013340"},{"key":"23_CR8","first-page":"111","volume":"56","author":"KS McCully","year":"1969","unstructured":"McCully KS (1969) Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56:111\u2013128","journal-title":"Am J Pathol"},{"key":"23_CR9","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1203\/00006450-197606000-00008","volume":"10","author":"YS Kanwar","year":"1976","unstructured":"Kanwar YS, Manaligod JR, Wong WK (1976) Morphologic studies in a patient with homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Pediatr Res 10:598\u2013609","journal-title":"Pediatr Res"},{"key":"23_CR10","first-page":"3198","volume":"36","author":"KS McCully","year":"1976","unstructured":"McCully KS (1976) Homocysteine thiolactone metabolism in malignant cells. Cancer Res 36:3198\u20133202","journal-title":"Cancer Res"},{"key":"23_CR11","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0014-5793(93)81283-6","volume":"317","author":"H Jakubowski","year":"1993","unstructured":"Jakubowski H, Goldman E (1993) Synthesis of homocysteine thiolactone by methionyl-tRNA synthetase in cultured malignant cells. FEBS Lett 317:237\u2013240","journal-title":"FEBS Lett"},{"key":"23_CR12","unstructured":"McCully KS (1981) Homocysteine thiolactone as a tumor promoter. US Patent 4,255,443, 10 Mar 1981"},{"key":"23_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000221970","volume":"23","author":"KS McCully","year":"1977","unstructured":"McCully KS, Clopath P (1977) Homocysteine compounds which influence the growth of a malignant neoplasm. Chemotherapy 23:44\u201349","journal-title":"Chemotherapy"},{"key":"23_CR14","unstructured":"McCully KS (1983) Homocysteine thiolactone salts and use thereof as antineoplastic agents. US Patent 4,383,994, 17 May 1983"},{"key":"23_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3109\/07357908709020303","volume":"5","author":"KS McCully","year":"1987","unstructured":"McCully KS, Vezeridis MP (1987) Antineoplastic activity of a rhodium trichloride complex of oxalyl homocysteine thiolactone. Cancer Investig 5:25\u201330","journal-title":"Cancer Investig"},{"key":"23_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3181\/00379727-180-42143","volume":"180","author":"KS McCully","year":"1985","unstructured":"McCully KS, Vezeridis MP (1985) Antineoplastic activity of N-maleamide homocysteine thiolactone amide encapsulated within liposomes. Proc Soc Exp Biol Med 180:57\u201361","journal-title":"Proc Soc Exp Biol Med"},{"key":"23_CR17","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1093\/carcin\/8.10.1559","volume":"8","author":"KS McCully","year":"1987","unstructured":"McCully KS, Vezeridis MP (1987) Chemopreventive and antineoplastic activity of N-homocysteine thiolactonyl retinamide. Carcinogenesis 8:1559\u20131562","journal-title":"Carcinogenesis"},{"key":"23_CR18","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3181\/00379727-191-42931","volume":"191","author":"KS McCully","year":"1989","unstructured":"McCully KS, Vezeridis MP (1989) Chemopreventive effect of N-homocysteine thiolactonyl retinamido cobalamin on carcinogenesis by ethyl carbamate in mice. Proc Soc Exp Biol Med 191:346\u2013351","journal-title":"Proc Soc Exp Biol Med"},{"issue":"6","key":"23_CR19","first-page":"179","volume":"5","author":"M Kazimir","year":"2002","unstructured":"Kazimir M, Wilson FR (2002) Prevention of homocysteine thiolactone induced atherosclerosis in rats. Res Commun Molec Pharmacol 5(6):179\u2013198","journal-title":"Res Commun Molec Pharmacol"},{"key":"23_CR20","unstructured":"McCully KS (1996) Thioretinaco ozonide and enhanced biological activity of thioretinaco ozonide in combination with interferon. US Patent 5,565,558, 15 Oct 1996"},{"key":"23_CR21","unstructured":"McCully KS (2004) Enhanced liposomal thioretinaco ozonide compositions and liposomal carrier. US Patent 6,696,082, 24 Feb 2004"},{"key":"23_CR22","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/231391a0","volume":"231","author":"KS McCully","year":"1971","unstructured":"McCully KS (1971) Homocysteine metabolism in scurvy, growth and arteriosclerosis. Nature 231:391\u2013392","journal-title":"Nature"},{"key":"23_CR23","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1126\/science.1257770","volume":"192","author":"P Clopath","year":"1976","unstructured":"Clopath P, Smith VC, McCully KS (1976) Growth promotion by homocysteic acid. Science 192:372\u2013374","journal-title":"Science"},{"key":"23_CR24","first-page":"147","volume":"5","author":"KS McCully","year":"1975","unstructured":"McCully KS (1975) Growth disorders and homocysteine metabolism. Ann Clin Lab Sci 5:147\u2013152","journal-title":"Ann Clin Lab Sci"},{"key":"23_CR25","first-page":"83","volume":"66","author":"KS McCully","year":"1972","unstructured":"McCully KS (1972) Macromolecular basis for homocysteine-induced changes in proteoglycan structure in growth and arteriosclerosis. Am J Pathol 66:83\u201395","journal-title":"Am J Pathol"},{"key":"23_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/978-1-4612-5006-7_25","volume-title":"Vitamins and cancer","author":"A Hanck","year":"1986","unstructured":"Hanck A (1986) Ascorbic acid and cancer. In: Myeskens FL Jr, Prasad KN Eds, Vitamins and cancer, Humana Press, Clifton, NJ, pp 365\u2013397"},{"key":"23_CR27","unstructured":"Warburg O (1931) The oxygen-transferring ferment of respiration. Nobel Lecture, 10 Dec 1931"},{"key":"23_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O (1956) On the origin of cancer cells. Science 123:309\u2013314","journal-title":"Science"},{"key":"23_CR29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1515\/bchm2.1961.323.1.155","volume":"323","author":"R Schon","year":"1961","unstructured":"Schon R, Menke KH, Negelein E (1961) The influence of heavy metal ions on the Ehrlich ascites tumor cells of mice and the effect of cysteine. Z Physiol Chem 323:155\u2013163","journal-title":"Z Physiol Chem"},{"key":"23_CR30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0009-2797(74)90019-2","volume":"9","author":"E Cameron","year":"1974","unstructured":"Cameron E, Campbell A (1974) The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem Biol Interact 9:285\u2013315","journal-title":"Chem Biol Interact"},{"key":"23_CR31","doi-asserted-by":"publisher","first-page":"4538","DOI":"10.1073\/pnas.75.9.4538","volume":"75","author":"E Cameron","year":"1978","unstructured":"Cameron E, Pauling L (1978) Supplemental ascorbate in the supportive treatment of cancer: reevaluation of survival times in terminal human cancer. Proc Natl Acad Sci U S A 75:4538\u20134542","journal-title":"Proc Natl Acad Sci U S A"},{"key":"23_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0899-9007(01)00783-3","volume":"18","author":"Y Ingenbleek","year":"2002","unstructured":"Ingenbleek Y, Hardillier E, Jung L (2002) Subclinical malnutrition is a determinant of hyperhomocysteinemia. Nutrition 18:40\u201346","journal-title":"Nutrition"},{"key":"23_CR33","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.nut.2011.04.009","volume":"28","author":"Y Ingenbleek","year":"2012","unstructured":"Ingenbleek Y, McCully KS (2012) Vegetarianism produces subclinical malnutrition, hyperhomocysteinemia and atherogenesis. Nutrition 28:148\u2013152","journal-title":"Nutrition"},{"issue":"7768","key":"23_CR34","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0140-6736(72)91596-6","volume":"2","author":"Y Ingenbleek","year":"1972","unstructured":"Ingenbleek Y, De Visscher M, De Nayer P et al (1972) Measurement of prealbumin as index of protein-calorie malnutrition. Lancet 2(7768):106\u2013109","journal-title":"Lancet"},{"key":"23_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2174\/1874241600902010049","volume":"2","author":"Y Ingenbleek","year":"2009","unstructured":"Ingenbleek Y (2009) Hyperhomocysteinemia is a biomarker for sulfur-deficiency in human morbidities. Open Clin Chem J 2:49\u201360","journal-title":"Open Clin Chem J"},{"key":"23_CR36","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1021\/bi700912k","volume":"47","author":"S Carballal","year":"2008","unstructured":"Carballal S, Madzelan P, Zinola CF et al (2008) Dioxygen reactivity and heme redox potential of truncated human cystathionine \u03b2-synthase. Biochemistry 47:3194\u20133202","journal-title":"Biochemistry"},{"key":"23_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0304-4165(91)90240-H","volume":"1075","author":"TJ Smith","year":"1991","unstructured":"Smith TJ, Drummond GS (1991) Retinoic acid can enhance the stimulation by thyroid hormone of heme oxygenase activity in the liver of thyroidectomized rats. Biochim Biophys Acta 1075:119\u2013122","journal-title":"Biochim Biophys Acta"},{"key":"23_CR38","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/jcp.20774","volume":"209","author":"W Samuel","year":"2006","unstructured":"Samuel W, Kutty RK, Nagineni S et al (2006) N-(4-hydroxyphenyl) retinamide induces apoptosis in human retinal pigment epithelial cells: retinoic acid receptors regulate apoptosis, reactive oxygen species generation, and the expression of heme oxygenase-1 and Gadd153. J Cell Physiol 209:854\u2013865","journal-title":"J Cell Physiol"},{"key":"23_CR39","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1007\/s10495-006-9289-3","volume":"11","author":"N Hail Jr","year":"2006","unstructured":"Hail N Jr, Kim HJ, Lotan R (2006) Mechanisms of fenretinide-induced apoptosis. Apoptosis 11:1677\u20131694","journal-title":"Apoptosis"},{"key":"23_CR40","doi-asserted-by":"publisher","first-page":"29871","DOI":"10.1074\/jbc.R400005200","volume":"279","author":"EW Miles","year":"2004","unstructured":"Miles EW, Kraus JP (2004) Cystathionine \u03b2-synthase: structure, function, regulation, and location of homocystinuria-causing mutations. J Biol Chem 279:29871\u201329874","journal-title":"J Biol Chem"},{"key":"23_CR41","first-page":"1449","volume":"21","author":"J Kim","year":"2009","unstructured":"Kim J, Hong SJ, Park JH et al (2009) Expression of cystathionine \u03b2-synthase is downregulated in hepatocellular carcinoma and associated with poor prognosis. Oncol Rep 21:1449\u20131454","journal-title":"Oncol Rep"},{"key":"23_CR42","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1126\/science.278.5340.1073","volume":"278","author":"WK Hong","year":"1997","unstructured":"Hong WK, Sporn MB (1997) Recent advances in chemoprevention of cancer. Science 278:1073\u20131077","journal-title":"Science"},{"key":"23_CR43","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V72.2.567.567","volume":"72","author":"ME Huang","year":"1988","unstructured":"Huang ME, Ye YI, Chen SR (1988) Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72:567\u2013572","journal-title":"Blood"},{"issue":"8665","key":"23_CR44","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/S0140-6736(89)90812-X","volume":"334","author":"C Chomienne","year":"1989","unstructured":"Chomienne C, Ballerini P, Balitrand N et al (1989) Retinoic acid therapy for promyelocytic leukaemia. Lancet 334(8665):746\u2013747","journal-title":"Lancet"},{"key":"23_CR45","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s00018-004-4002-6","volume":"61","author":"AM Simeone","year":"2004","unstructured":"Simeone AM, Tari AM (2004) How retinoids regulate breast cancer cell proliferation and apoptosis. Cell Mol Life Sci 61:1475\u20131484","journal-title":"Cell Mol Life Sci"},{"key":"23_CR46","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1021\/bi7003069","volume":"46","author":"AR Moise","year":"2007","unstructured":"Moise AR, Noy N, Palczewski K, Blaner WS (2007) Delivery of retinoid-based therapies to target tissues. Biochemistry 46:4449\u20134458","journal-title":"Biochemistry"},{"key":"23_CR47","first-page":"222","volume":"45","author":"KS McCully","year":"2015","unstructured":"McCully KS (2015) The active site of oxidative phosphorylation and the origin of hyperhomocysteinemia in aging and dementia. Ann Clin Lab Sci 45:222\u2013225","journal-title":"Ann Clin Lab Sci"},{"key":"23_CR48","unstructured":"Beard J (1911) The enzymatic treatment of cancer and its scientific basis. Chatto & Windus, London, 1911, republished by New Spring Press, New York, 2010 with a foreword by Nicholas Gonzalez"},{"key":"23_CR49","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/1097-0142(19951015)76:8<1467::AID-CNCR2820760826>3.0.CO;2-A","volume":"76","author":"HF Acevedo","year":"1995","unstructured":"Acevedo HF, Tong JY, Hartsock RJ (1995) Human chorionic gonadotropin-beta subunit gene expression in cultured human fetal and cancer cells of different types and origins. Cancer 76:1467\u20131475","journal-title":"Cancer"},{"key":"23_CR50","first-page":"1157","volume":"25","author":"JF Novak","year":"2005","unstructured":"Novak JF, Trynka F (2005) Proenzyme therapy of cancer. Anticancer Res 25:1157\u20131178","journal-title":"Anticancer Res"},{"key":"23_CR51","volume-title":"The trophoblast and the origins of cancer","author":"N Gonzalez","year":"2009","unstructured":"Gonzalez N, Isaacs L (2009) The trophoblast and the origins of cancer. New Spring Press, New York"},{"key":"23_CR52","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00726-006-0432-9","volume":"32","author":"J Perla-Kajan","year":"2007","unstructured":"Perla-Kajan J, Twardowski T, Jakubowski H (2007) Mechanisms of homocysteine toxicity in humans. Amino Acids 32:561\u2013572","journal-title":"Amino Acids"},{"key":"23_CR53","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1203\/00006450-197206000-00002","volume":"6","author":"G Gaull","year":"1972","unstructured":"Gaull G, Sturman JA, Raiha NCR (1972) Development of mammalian sulfur metabolism: absence of cystathionase in fetal tissues. Pediatr Res 6:538\u2013547","journal-title":"Pediatr Res"},{"key":"23_CR54","first-page":"701","volume":"46","author":"KS McCully","year":"2016","unstructured":"McCully KS (2016) Homocysteine, thioretinaco ozonide, oxidative phosphorylation, biosynthesis of phosphoadenosine phosphosulfate and the pathogenesis of atherosclerosis. Ann Clin Lab Sci 46:701\u2013704","journal-title":"Ann Clin Lab Sci"},{"key":"23_CR55","first-page":"353","volume":"3","author":"WC Schneider","year":"1943","unstructured":"Schneider WC, Potter VR (1943) Biocatalysts in cancer tissue. III. Succinic dehydrogenase and cytochrome oxidase. Cancer Res 3:353\u2013357","journal-title":"Cancer Res"},{"key":"23_CR56","first-page":"1","volume-title":"The nitrilosides in the prevention and control of cancer","author":"ET Krebs Jr","year":"1962","unstructured":"Krebs ET Jr (1962) The nitrilosides in the prevention and control of cancer. McNaughton Foundation, Los Angeles, pp 1\u201321"},{"key":"23_CR57","doi-asserted-by":"publisher","first-page":"F410","DOI":"10.1152\/ajprenal.00145.2009","volume":"297","author":"U Sen","year":"2009","unstructured":"Sen U, Basu P, Abe OA et al (2009) Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure. Am J Physiol Renal Physiol 297:F410\u2013F419","journal-title":"Am J Physiol Renal Physiol"},{"key":"23_CR58","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1089\/ars.2009.2921","volume":"12","author":"KR Olson","year":"2010","unstructured":"Olson KR, Whitfield NL (2010) Hydrogen sulfide and oxygen sensing in the cardiovascular system. Antioxid Redox Signal 12:1219\u20131234","journal-title":"Antioxid Redox Signal"},{"key":"23_CR59","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00726-007-0011-8","volume":"34","author":"L Chang","year":"2008","unstructured":"Chang L, Geng B, Yu F et al (2008) Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats. Amino Acids 34:573\u2013585","journal-title":"Amino Acids"},{"key":"23_CR60","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1161\/CIRCRESAHA.114.300505","volume":"114","author":"DJ Polhemus","year":"2014","unstructured":"Polhemus DJ, Lefer DJ (2014) Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease. Circ Res 114:730\u2013737","journal-title":"Circ Res"},{"key":"23_CR61","doi-asserted-by":"publisher","first-page":"15560","DOI":"10.1073\/pnas.0705891104","volume":"104","author":"JW Elrod","year":"2007","unstructured":"Elrod JW, Calvert JW, Morrison J et al (2007) Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci U S A 104:15560\u201315565","journal-title":"Proc Natl Acad Sci U S A"},{"key":"23_CR62","doi-asserted-by":"publisher","first-page":"17977","DOI":"10.1073\/pnas.0705710104","volume":"104","author":"GA Benavides","year":"2007","unstructured":"Benavides GA, Squadrito GL, Mills RW et al (2007) Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci U S A 104:17977\u201317982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"23_CR63","doi-asserted-by":"publisher","first-page":"745S","DOI":"10.1093\/jn\/136.3.745S","volume":"136","author":"YY Yeh","year":"2006","unstructured":"Yeh YY, Yeh SM (2006) Homocysteine-lowering action is another potential cardiovascular protective factor of aged garlic extract. J Nutr 136:745S\u2013749S","journal-title":"J Nutr"},{"key":"23_CR64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.intimp.2016.04.015","volume":"36","author":"LY Chen","year":"2016","unstructured":"Chen LY, Chen Q, Zhu XJ et al (2016) Diallyl trisulfide protects against ethanol-induced oxidative stress and apoptosis via a hydrogen sulfide-mediated mechanism. Int Immunopharmacol 36:23\u201330","journal-title":"Int Immunopharmacol"},{"key":"23_CR65","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.ijcard.2012.12.004","volume":"168","author":"CY Tsai","year":"2013","unstructured":"Tsai CY, Wang CC, Lai TY et al (2013) Antioxidant effects of diallyl trisulfide on high glucose-induced apoptosis are mediated by the PI3K\/Akt-dependent activation of Nrf2 in cardiomyocytes. Int J Cardiol 168:1286\u20131297","journal-title":"Int J Cardiol"},{"key":"23_CR66","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ijcard.2015.05.111","volume":"195","author":"CY Tsai","year":"2015","unstructured":"Tsai CY, Wen SY, Shibu MA et al (2015) Diallyl trisulfide protects against high glucose-induced cardiac apoptosis by stimulating the production of cystathionine gamma-lyase-derived hydrogen sulfide. Int J Cardiol 195:300\u2013310","journal-title":"Int J Cardiol"},{"key":"23_CR67","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/cncr.22888","volume":"110","author":"A Das","year":"2007","unstructured":"Das A, Banik NL, Ray SK (2007) Garlic compounds generate reactive oxygen species leading to activation of stress kinases and cysteine proteases for apoptosis in human glioblastoma T98G and U87MG cells. Cancer 110:1083\u20131094","journal-title":"Cancer"},{"key":"23_CR68","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.bcp.2012.08.024","volume":"84","author":"HK Na","year":"2012","unstructured":"Na HK, Kim EH, Choi MA et al (2012) Diallyl trisulfide induces apoptosis in human breast cancer cells through ROS-mediated activation of JNK and AP-1. Biochem Pharmacol 84:1241\u20131250","journal-title":"Biochem Pharmacol"},{"key":"23_CR69","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10549-013-2440-2","volume":"138","author":"K Chandra-Kuntal","year":"2013","unstructured":"Chandra-Kuntal K, Lee J, Singh SV (2013) Critical role for reactive oxygen species in apoptosis induction and cell migration inhibition by diallyl trisulfide, a cancer chemopreventive component of garlic. Breast Cancer Res Treat 138:69\u201379","journal-title":"Breast Cancer Res Treat"},{"key":"23_CR70","first-page":"e1023781","volume":"10","author":"Y Liu","year":"2015","unstructured":"Liu Y, Zhu P, Wang Y et al (2015) Antimetastatic therapies of the polysulfide diallyl trisulfide against triple-negative breast cancer (TNBC) via suppression MMP2\/9 by blocking NF-\u03baB and ERK\/MAPK signaling pathways. PLoS One 10:e1023781","journal-title":"PLoS One"},{"key":"23_CR71","doi-asserted-by":"publisher","first-page":"13495","DOI":"10.1074\/jbc.M116.715219","volume":"291","author":"SH Kim","year":"2016","unstructured":"Kim SH, Kaschula CH, Priedigkeit N et al (2016) Forkhead box Q1 is a novel target of breast cancer stem cell inhibition by diallyl trisulfide. J Biol Chem 291:13495\u201313508","journal-title":"J Biol Chem"},{"key":"23_CR72","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1749-6632.2012.06743.x","volume":"1271","author":"HC Wang","year":"2012","unstructured":"Wang HC, Pao J, Lin SY et al (2012) Molecular mechanisms of garlic-derived allyl sulfides in the inhibition of skin cancer progression. Ann N Y Acad Sci 1271:44\u201352","journal-title":"Ann N Y Acad Sci"},{"key":"23_CR73","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3748\/wjg.v20.i1.193","volume":"20","author":"HB Ma","year":"2014","unstructured":"Ma HB, Huang S, Yin XR et al (2014) Apoptotic pathway induced by diallyl trisulfide in pancreatic cancer cells. World J Gastroenterol 20:193\u2013203","journal-title":"World J Gastroenterol"},{"key":"23_CR74","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0304-3835(00)00552-8","volume":"160","author":"T Seki","year":"2000","unstructured":"Seki T, Tsuji K, Hayato Y et al (2000) Garlic and onion oils inhibit proliferation and induce differentiation of HL-60 cells [human promyelocytic leukemia cells]. Cancer Lett 160:29\u201335","journal-title":"Cancer Lett"},{"key":"23_CR75","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1365-2141.2005.05803.x","volume":"131","author":"JC Desmond","year":"2005","unstructured":"Desmond JC, Kawabata H, Mueller-Tidow C et al (2005) The synthetic furanonapthoquinone induces growth arrest, apoptosis and differentiation in a variety of leukaemias and multiple myeloma cells. Brit J Haematol 131:520\u2013529","journal-title":"Brit J Haematol"},{"key":"23_CR76","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/0031-9422(96)00135-5","volume":"42","author":"S Gafner","year":"1996","unstructured":"Gafner S, Wolfender JL, Nianga M et al (1996) Antifungal and antibacterial napthoquinones from Newbouldia laevis roots. Phytochemistry 42:1315\u20131320","journal-title":"Phytochemistry"},{"key":"23_CR77","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0031-9422(03)00277-2","volume":"64","author":"R Gormann","year":"2003","unstructured":"Gormann R, Kaloga M, Li XC et al (2003) Furanonaphthoquinones, atraric acid and a benzofuran from stem barks of Newbouldia laevis. Phytochemistry 64:583\u2013587","journal-title":"Phytochemistry"},{"key":"23_CR78","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1021\/np990528l","volume":"63","author":"SR Peraza-Sanchez","year":"2000","unstructured":"Peraza-Sanchez SR, Chavez D, Chai HB et al (2000) Cytotoxic constituents of the roots of Ekmanianthe longiflora. J Nat Prod 63:492\u2013495","journal-title":"J Nat Prod"},{"key":"23_CR79","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0304-3835(01)00707-8","volume":"174","author":"M Itoigawa","year":"2001","unstructured":"Itoigawa M, Ito C, Tan HTW et al (2001) Cancer chemopreventive activity of naphthoquinones and their analogs from Avicennia plants. Cancer Lett 174:135\u2013139","journal-title":"Cancer Lett"},{"key":"23_CR80","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1271\/bbb.70.1009","volume":"70","author":"M Ogawa","year":"2006","unstructured":"Ogawa M, Koyanagi J, Sugaya A et al (2006) Cytotoxic activity toward KB cells of 2-substituted naphtho[2,3-b]furan-4,9-diones and their related compounds. Biosci Biotechnol Biochem 70:1009\u20131012","journal-title":"Biosci Biotechnol Biochem"},{"key":"23_CR81","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1055\/s-2006-931554","volume":"72","author":"RB Williams","year":"2006","unstructured":"Williams RB, Norris A, Miller JS et al (2006) Two new cytotoxic naphthoquinones from Mendoncia cowanii from the rainforest of Madagascar. Planta Med 72:564\u2013566","journal-title":"Planta Med"},{"key":"23_CR82","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.1073\/pnas.0409894102","volume":"102","author":"H Song","year":"2005","unstructured":"Song H, Wang R, Wang S, Lin J (2005) A low-molecular weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells. Proc Natl Acad Sci U S A 102:4700\u20134705","journal-title":"Proc Natl Acad Sci U S A"},{"key":"23_CR83","unstructured":"Jiang Z, Chiang JL, Leggett D (2014) STAT3 pathway inhibitors and cancer stem cell inhibitors. US Patent 8,877,803, 4 Nov 2014"},{"key":"23_CR84","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1073\/pnas.1424171112","volume":"112","author":"Y Li","year":"2015","unstructured":"Li Y, Rogoff HA, Keates S et al (2015) Suppression of cancer relapse and metastasis by inhibiting cancer stemness. Proc Natl Acad Sci U S A 112:1839\u20131844","journal-title":"Proc Natl Acad Sci U S A"},{"key":"23_CR85","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/cam4.675","volume":"5","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Jin Z, Zhou H et al (2016) Suppression of prostate cancer progression by cancer cell stemness inhibitor napabucasin. Cancer Med 5:1251\u20131258","journal-title":"Cancer Med"},{"key":"23_CR86","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1158\/1940-6207.CAPR-10-0123","volume":"3","author":"K Chandra-Kuntal","year":"2010","unstructured":"Chandra-Kuntal K, Singh SV (2010) Diallyl trisulfide inhibits activation of Signal Transducer and Activator of Transcription 3 in prostate cancer cells in culture and in vivo. Cancer Prev Res (Phila) 3:1473\u20131483","journal-title":"Cancer Prev Res (Phila)"},{"key":"23_CR87","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bbrc.2013.06.064","volume":"437","author":"HJ Lee","year":"2013","unstructured":"Lee HJ, Lee HG, Choi KS et al (2013) Diallyl trisulfide suppresses dextran sodium sulfate-induced mouse colitis: NF\u03baB and STAT3 as potential targets. Biochem Biophys Res Commun 437:267\u2013273","journal-title":"Biochem Biophys Res Commun"},{"key":"23_CR88","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3109\/10428190109057963","volume":"41","author":"A Cortelezzi","year":"2001","unstructured":"Cortelezzi A, Fracchiolla NS, Bamonti-Catena F et al (2001) Hyperhomocysteinemia in myelodysplastic syndromes: specific association with autoimmunity and cardiovascular disease. Leuk Lymphoma 41:147\u2013150","journal-title":"Leuk Lymphoma"},{"key":"23_CR89","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/BOR.0b013e32834db4ee","volume":"24","author":"S Giannouli","year":"2012","unstructured":"Giannouli S, Kanellopoulou T, Voulegarelis M (2012) Myelodysplasia and autoimmunity. Curr Opin Rheumatol 24:97\u2013102","journal-title":"Curr Opin Rheumatol"},{"key":"23_CR90","first-page":"594","volume":"88","author":"NS Fracchiolla","year":"2003","unstructured":"Fracchiolla NS, Catena FB, Novembrino C et al (2003) Possible association between reactive oxygen metabolites and karyotypic abnormalities in myelodysplastic syndromes. Haematologica 88:594\u2013597","journal-title":"Haematologica"},{"key":"23_CR91","doi-asserted-by":"publisher","first-page":"416028","DOI":"10.1155\/2014\/416028","volume":"2014","author":"K Pimkova","year":"2014","unstructured":"Pimkova K, Chrastinova L, Suttnar J et al (2014) Plasma levels of aminothiols, nitrite, nitrate, and malondialdehyde in myelodysplastic syndromes in the context of clinical outcomes and as a consequence of iron overload. Oxidative Med Cell Longev 2014:416028","journal-title":"Oxidative Med Cell Longev"},{"key":"23_CR92","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0145-2126(99)00165-4","volume":"24","author":"A Cortelezzi","year":"1999","unstructured":"Cortelezzi A, Cattaneo C, Sarina B et al (1999) Efficacy of N-acetylcysteine and all-trans-retinoic acid in restoring in vitro effective hemopoiesis in myelodysplastic syndromes. Leuk Res 24:129\u2013137","journal-title":"Leuk Res"},{"key":"23_CR93","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1182\/blood-2007-08-078139","volume":"111","author":"SD Nimer","year":"2008","unstructured":"Nimer SD (2008) Myelodysplastic syndromes. Blood 111:4841\u20134851","journal-title":"Blood"},{"key":"23_CR94","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3324\/haematol.2009.010611","volume":"95","author":"R Gurion","year":"2010","unstructured":"Gurion R, Vidal L, Gafter-Gvilli A et al (2010) 5-azacytidine prolongs overall survival in patients with myelodysplastic syndrome\u2014a systematic review and meta-analysis. Haematologica 95:303\u2013310","journal-title":"Haematologica"},{"key":"23_CR95","unstructured":"\u201cPrescribing information\u2014Azacytidine for Infection\u201d (2016) fda.gov United States Food and Drug Administration"},{"key":"23_CR96","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1182\/blood-2013-04-494930","volume":"122","author":"A Jerez","year":"2013","unstructured":"Jerez A, Clemente MJ, Makishima H et al (2013) STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplasia syndrome patients. Blood 122:2453\u20132459","journal-title":"Blood"},{"key":"23_CR97","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1182\/blood-2013-08-521138","volume":"122","author":"KR Schultz","year":"2013","unstructured":"Schultz KR (2013) STAT3 mutations and persistence of autoimmunity. Blood 122:2295\u20132296","journal-title":"Blood"},{"key":"23_CR98","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1158\/1078-0432.CCR-15-1288","volume":"22","author":"P Mitiades","year":"2016","unstructured":"Mitiades P, Lamprianidou E, Vassilakopoulos TP et al (2016) The Stat 3\/5 signaling biosignature in hematopoietic stem\/progenitor cells predicts response and outcome in myelodysplastic syndrome patients treated with azacytidine. Clin Cancer Res 22:1958\u20131968","journal-title":"Clin Cancer Res"},{"key":"23_CR99","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","volume":"125","author":"JD Milner","year":"2015","unstructured":"Milner JD, Vogel TP, Forbes L et al (2015) Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood 125:591\u2013599","journal-title":"Blood"},{"key":"23_CR100","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1182\/blood-2014-04-570101","volume":"125","author":"EM Haapaniemi","year":"2015","unstructured":"Haapaniemi EM, Kaustio M, Rajala HLM et al (2015) Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3. Blood 125:639\u2013648","journal-title":"Blood"},{"key":"23_CR101","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.4049\/jimmunol.179.7.4313","volume":"179","author":"TJ Harris","year":"2007","unstructured":"Harris TJ, Grosso JF, Yen HR et al (2007) An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J Immunol 179:4313\u20134317","journal-title":"J Immunol"},{"key":"23_CR102","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1096\/fj.10-175299","volume":"25","author":"S Zhang","year":"2011","unstructured":"Zhang S, Zheng M, Kibe R et al (2011) Trp53 negatively regulates autoimmunity via the STAT3-Th17 axis. FASEB J 25:2387\u20132398","journal-title":"FASEB J"},{"key":"23_CR103","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cbi.2016.10.010","volume":"260","author":"S Daw","year":"2016","unstructured":"Daw S, Chatterjee R, Law A et al (2016) Analysis of hematopathology and alteration of JAK1\/STAT3\/STAT5 signaling axis in experimental myelodysplastic syndrome. Chem Biol Interact 260:176\u2013185","journal-title":"Chem Biol Interact"},{"key":"23_CR104","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.4049\/jimmunol.1403088","volume":"198","author":"SY Lee","year":"2017","unstructured":"Lee SY, Moon SJ, Kim EK et al (2017) Metformin suppresses systemic autoimmunity in Roquinsan\/san mice through inhibiting B cell differentiation into plasma cells via regulation of AMPK\/mTOR\/STAT3. J Immunol 198:2661\u20132670","journal-title":"J Immunol"},{"key":"23_CR105","unstructured":"McCully KS (2015) Compositions and method for utilization of thioretinamide in therapy of diseases of aging. US Patent No. 9,216,209. 22 Dec 2015"},{"key":"23_CR106","unstructured":"McCully KS (2017) Thioretinamide compositions for the apoptosis of malignant cells while preventing the apoptosis of normal cells and related methods. US Continuing Patent Application S.N. 15\/475,103, 30 Mar 2017"},{"key":"23_CR107","unstructured":"Kazimir M, Wilson R (2000) Method for synthesis of N-homocysteine thiolactonyl retinamide. US Patent 6,054,595, 25 Apr 2000"}],"container-title":["Methods in Molecular Biology","Methionine Dependence of Cancer and Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-8796-2_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T01:15:52Z","timestamp":1573866952000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-8796-2_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9781493987955","9781493987962"],"references-count":107,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-8796-2_23","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"7 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}